A year ago, applications for a cell-cultured foie gras product were dropped off at the United States Food and Drug ...

HistoIndex’s AI-based FibroSIGHT Plus’s launch coincides with the MASH space’s pharma market potential swelling across the ...

Illustrative Image of Respiree’s RS001 Wearable With its Connected Care 1Bio™ Platform The RS001 is a chest-worn device that ...

Novo Nordisk expects continued competition from copycat versions of its blockbuster Wegovy obesity drug this year and could ...

Dear reader, according to recent reports and statistics from the Saudi Food and Drug Authority (SFDA), significant and ...

Genting Bhd is poised to benefit from the continued earnings recovery of its key subsidiaries, Genting Malaysia Bhd (GenM) ...

With the U.S. Food and Drug Administration (FDA) announcing the phased abolition of animal testing, organoid-based ...

Burns repair house Avita Medical has shored up its balance sheet with a $23 million placement, prompting a 13% share surge.

Detailed price information for Lenz Therapeutics Inc (LENZ-Q) from The Globe and Mail including charting and trades.

The U.S. Food and Drug Administration approved a new blue color additive derived from the fruit of the gardenia, a flowering evergreen, for use in a variety of drinks and candies.

The U.S. Food and Drug Administration on Monday approved the use of a new blue color additive from the gardenia fruit the fourth coloring from natural sources added in the last two months.